[HTML][HTML] COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
COVID-19-infected individuals and those who recovered from the infection have been
demonstrated to have elevated liver enzymes or abnormal liver biochemistries, particularly …
demonstrated to have elevated liver enzymes or abnormal liver biochemistries, particularly …
The effect of nitazoxanide on the clinical outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Abstract Background and Objective Nitazoxanide, a US Food and Drug Administration-
approved antiparasitic agent, was reported to be effective in treating coronavirus disease …
approved antiparasitic agent, was reported to be effective in treating coronavirus disease …
[HTML][HTML] Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods
Background Pfizer in the USA has pioneered an orally active drug called Nirmatrelvir (PF-
07321332) targeting the main protease (Mpro) protein of SARS-CoV-2. However, the current …
07321332) targeting the main protease (Mpro) protein of SARS-CoV-2. However, the current …
Rapid and validated UHPLC method for simultaneous determination of sofosbuvir, ledipasvir and paracetamol as commonly repurposed drugs for COVID-19 …
Abstract Background Sofosbuvir/ledipasvir (SOF/LDV), a combination of antiviral drugs, has
been recently repurposed for COVID-19 management, according to Food and Drug …
been recently repurposed for COVID-19 management, according to Food and Drug …
Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 …
Background COVID-19 has emerged as the most serious outbreak in recent years. Certain
medications such as sofosbuvir (SOF), ledipasvir (LDV) and paracetamol (PAR) were …
medications such as sofosbuvir (SOF), ledipasvir (LDV) and paracetamol (PAR) were …
Computational insights into pediatric adenovirus inhibitors: in silico strategies for drug repurposing
Human adenovirus (HADV) infection can pose a serious threat to children, leading to a
variety of respiratory illnesses and other complications. Particularly, children with weak …
variety of respiratory illnesses and other complications. Particularly, children with weak …
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized …
TC Weng, TS Weng, CC Lai, CM Chao… - Expert Review of Anti …, 2022 - Taylor & Francis
Background This study investigated the clinical outcomes, virological efficacy and safety of
nitazoxanide in the treatment of patients with COVID-19. Research design and methods The …
nitazoxanide in the treatment of patients with COVID-19. Research design and methods The …
[HTML][HTML] Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
DD Stewart - Clinical Case Reports, 2023 - ncbi.nlm.nih.gov
Long COVID or post‐acute sequelae of COVID‐19 (PASC) continues to affect many people
even after a relatively mild acute illness. Underlying causes of PASC are poorly understood …
even after a relatively mild acute illness. Underlying causes of PASC are poorly understood …
PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY.
JA Pereira, ED Costa - Indian Drugs, 2024 - search.ebscohost.com
Studies on the development of effective and cost-effective oral drugs are the new priority of
the pharmaceutical industry for the prevention and treatment of COVID-19. This work was …
the pharmaceutical industry for the prevention and treatment of COVID-19. This work was …